Recalls & Warnings April 17, 2020 Joint Pain Supplement Isoprex Settles Charges of Making False Claims On April 16, 2020, Renaissance Health Publishing, LLC, agreed to halt their allegedly deceptive advertising claims about their Isoprex supplement that targeted older consumers nationwide after the Federal Trade Commission (FTC) filed a complaint
In a 2024 review of three peptides, the FDA noted side effects like increased heart rate, chest tightening, headache, nausea, diarrhea, and elevated liver enzymes, as well as skin irritation and pain at the injection site
Follow the product labeling and your protocol
Some combinations have become so well-established that suppliers now offer pre-blended formulations, while others remain areas of active investigation